Skip to content
Screener

GRAIL, Inc. GRAL Business Segments — Net loss

Similar metrics at other companies

Veradermics logo
MANEReportable Segment — Net loss
-$27.23M-120%
Zscaler logo
ZSReportable Segment — Net loss
-$13.88M-237%
Biohaven logo
BHVNReportable Segment — Net loss
-$130.53M+41.1%
Bicara Therapeutics logo
BCAXReportable Segment — Net loss
-$56.21M-52.6%
YSS
YSSReportable Segment — Net loss
-$114.84M-879%
Vaxcyte, Inc. logo
PCVXReportable Segment — Net loss
-$320.62M-128%

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%
P/S16.5×+7.6×

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Return on equity-16.1%-1.3pp
Debt / equity0.0×
Current ratio10.9×+1.7×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307
Line itemThree Months Ended / June 30,2026Three Months Ended / June 30,2025Six Months Ended / June 30,2026Six Months Ended / June 30,2025
Interest income7,2306,80915,21614,588
Other income (expense), net(155)(811)101(1,395)
Total other income, net7,0755,99815,31713,193
Loss before income taxes(166,708)(152,856)(294,231)(299,268)
Benefit from income taxes56,46138,87190,79779,070
Net loss$(110,247)$(113,985)$(203,434)$(220,198)
Net loss per share — Basic and Diluted$(2.56)$(3.18)$(4.86)$(6.28)
Weighted-average shares of common stock used in computing net loss per share:43,112,59535,793,15441,883,56535,054,896

Item 1. Financial Statements

FAQ

What is GRAIL, Inc.'s business segments — net loss?
GRAIL, Inc. (GRAL) reported business segments — net loss of -$110.25M in Q2 2026.
How has GRAIL, Inc.'s business segments — net loss changed year-over-year?
GRAIL, Inc.'s business segments — net loss increased by 3.3% year-over-year, from -$113.99M to -$110.25M.
What is the long-term trend for GRAIL, Inc.'s business segments — net loss?
Over 3 years (2022 to 2025), GRAIL, Inc.'s business segments — net loss has grown at a -57.7% compound annual growth rate (CAGR), from -$5.4B to -$408.35M.
What does business segments — net loss mean?
This is the bottom-line financial result for the business segment after accounting for all revenues, operating expenses, interest, taxes, and non-operating items. It indicates the total economic loss generated by the segment during the period. For growth-stage companies, this metric is critical for evaluating the burn rate and the timeline to achieving segment-level profitability.

Ask your AI about GRAIL, Inc.'s business segments — net loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude